// App-Quantinova.ai

OC 73.3 : Thrombopoietin receptor agonists (TPO-RAs) in older patients with primary immune thrombocytopenia (ITP): effective and safe? Real World Data from the UK adult ITP registry.

Researchers

Presenter

  • P. Raheja

Principal Investigators

  • A. Miah

  • L. Taylor

  • T. Biss

  • G. Evans

  • M. Scully

  • S. Marshall

  • M. Kilner

  • R. Rayment

  • L. Robinson

  • S. Johns

  • C. Rinaldi

  • H. Jackson

  • S. Ackroyd

  • A. Newland

  • D. Provan

  • N. Cooper

  • V. McDonald

Medical Centers

  • Royal London Hospital London London United Kingdom

  • Queen Mary University of London, London, United Kingdom

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

  • East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

  • University College Hospitals London NHS Foundation Trust, London, England, United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Sunderland Royal Hospital, Sunderland, UK, Sunderland, United Kingdom

  • Northumbria Healthcare NHS FoundationTrust, Northumbria, UK

  • Cardiff and Vale, University Hospital of Wales, Cardiff, England, United Kingdom

  • County Hospital, Wye Valley NHS Trust (Hereford), Wye, England, United Kingdom

  • Royal Cornwall Hospital, Cornwall, England, United Kingdom

  • Pilgrim Hospital, Pilgrim, England, United Kingdom

  • Aneurin Bevan University Health Board, Royal Gwent, Gwent, England, United Kingdom

  • Bradford Royal Infirmary, Bradford, United Kingdom

  • Hammersmith Hospital, London, England, United Kingdom

  • Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved